| Brain FDG-PET imaging in long COVID patients R Amiruddin, M Alatout, F Yazdanpanah, SAA Mhana, W Raynor, ... Journal of Nuclear Medicine 65 (supplement 2), 242351-242351, 2024 | | 2024 |
| Utility of PET/CT in management of patients undergoing renal cryoablation O Al-Daoud, F Yazdanpanah, M Alatout, M Moradpour, T Werner, A Alavi, ... Journal of Nuclear Medicine 65 (supplement 2), 241071-241071, 2024 | | 2024 |
| Metabolic Changes in Recurrent Cancer After Cryoablation: PET/CT Volumetric Parameter Analysis O Al-Daoud, F Yazdanpanah, M Alatout, M Moradpour, T Werner, A Alavi, ... Journal of Nuclear Medicine 65 (supplement 2), 241070-241070, 2024 | | 2024 |
| Dose Precision Assessment with Pre-Treatment 99mTc-MAA SPECT/CT in 90Y Radioembolization for Hepatocellular Carcinoma F Yazdanpanah, O Al-Daoud, M Moradpour, T Werner, A Alavi, S Hunt Journal of Nuclear Medicine 65 (supplement 2), 241230-241230, 2024 | | 2024 |
| Alavi-Carlsen Calcification Score (ACCS): A New Criterion of Global Cardiac Atherosclerosis Burden O Al-Daoud, F Yazdanpanah, M Alatout, M Moradpour, T Werner, A Alavi Journal of Nuclear Medicine 65 (supplement 2), 241738-241738, 2024 | | 2024 |
| Optimizing Predictive Models for 90Y Radioembolization Response Based on PET/CT Radiomics Features F Yazdanpanah, O Al-Daoud, A Pannu, M Moradpour, T Werner, A Alavi, ... Journal of Nuclear Medicine 65 (supplement 2), 241232-241232, 2024 | | 2024 |
| The Role of FDG-PET/CT in Evaluating Ablation of Lung Malignancies O Al-Daoud, F Yazdanpanah, M Alatout, M Moradpour, T Werner, A Alavi, ... Journal of Nuclear Medicine 65 (supplement 2), 241737-241737, 2024 | | 2024 |
| Utility of Quantitative PET in Characterizing Malignant Liver Masses in Patients Undergoing Ablation F Yazdanpanah, O Al-Daoud, M Alatout, M Moradpour, T Werner, A Alavi, ... Journal of Nuclear Medicine 65 (supplement 2), 241229-241229, 2024 | | 2024 |
| Abstract No. 153 Pretreatment Sarcopenia Predicts Outcomes Post TACE F Yazdanpanah, O Shafaat, O Al Daoud, M Al-Atout, G Nadolski, T Gade, ... Journal of Vascular and Interventional Radiology 35 (3), S69, 2024 | | 2024 |
| Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 M Safdarian, E Trinka, V Rahimi-Movaghar, A Thomschewski, A Aali, ... The Lancet Neurology 22 (11), 1026-1047, 2023 | 24 | 2023 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 17 | 2023 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBD 2021 Anaemia Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 73 | 2023 |
| Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 S Azadnajafabad, S Saeedi Moghaddam, E Mohammadi, N Rezaei, ... Frontiers in Oncology 13, 1132816, 2023 | 5 | 2023 |
| Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease … ML Ferreira, K De Luca, LM Haile, JD Steinmetz, GT Culbreth, M Cross, ... The Lancet Rheumatology 5 (6), e316-e329, 2023 | 281 | 2023 |
| Machine learning based radiomics features of theranostics PET features in detection of Prostate cancer (PCa): a systematic review of 1703 patients F Yazdanpanah, S Houshi, M Hosseini, S Bagherieh, SF Nejati, H ARABI, ... Journal of Nuclear Medicine 64 (supplement 1), P1576-P1576, 2023 | 2 | 2023 |
| Fibroblast Activation Protein (FAP): an overview for trainees F Yazdanpanah, R Subtirelu, E Teichner, T Werner, M Morris, ... Journal of Nuclear Medicine 64 (supplement 1), P1534-P1534, 2023 | | 2023 |
| Modeling of Tumor Microenvironment F Yazdanpanah, R Subtirelu, E Teichner, S Bagherieh, SF Nejati, ... Journal of Nuclear Medicine 64 (supplement 1), P1566-P1566, 2023 | | 2023 |
| Cancer associated fibroblasts: Beyond the basics F Yazdanpanah, E Teichner, R Subtirelu, M Morris, ME Revheim, ... Journal of Nuclear Medicine 64 (supplement 1), P1538-P1538, 2023 | | 2023 |
| Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019 S Moradi, A Parsaei, S Saeedi Moghaddam, A Aryannejad, ... Frontiers in public health 11, 1149719, 2023 | 3 | 2023 |
| The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study MR Malekpour, M Abbasi-Kangevari, SH Ghamari, J Khanali, ... EClinicalMedicine 60, 2023 | 6 | 2023 |
Pedram Keshavarz, MDPostdoc Research Fellow at UCLA在 mednet.ucla.edu 的电子邮件经过验证
